• Home
  • Index Entries
  • Topics
  • Want to help?
  • More...
    • Book a Speaker
    • Publicity
    • What is the Covid Narrative?
    • FAQ
    • Acknowledgments
    • Glossary
    • Contact
    • The Covid Index T-shirt
  • Login
☰
×
  • Home
  • Index Entries
  • Topics
  • Want to help?
  • More...
    • Book a Speaker
    • Publicity
    • What is the Covid Narrative?
    • FAQ
    • Acknowledgments
    • Glossary
    • Contact
    • The Covid Index T-shirt
  • Login

fluvoxamine

pharmaceuticals
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial
Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19
1031

The Covid Index is for informational, non-profit
purposes only, and it is not predictive or prescriptive. So
please think for yourself, do your own due diligence,
and draw your own (well-informed) conclusions.

Terms of Use

Privacy Policy

© 2023 - 2025 Children's Health Defense® • All rights reserved

To Top

To become a valued Research Associate, click here.

To book a Covid Index spokesperson for your podcast or event, click here.